Utente: Anonimo
ELENCO COMUNICATI STAMPA Feed RSS per la notifica dei nuovi comunicati pubblicati su informazione.it
12345678910...
27/02/2015
 13.45
Novartis shareholders approve all resolutions proposed by Novartis Board of Directors
Novartis International AG / Novartis shareholders approve all resolutions proposed by Novartis Board of Directors . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. * Shareholders approve 18(th) consecutive dividend increase to CHF 2.60 (+6%) per share for 2014 * Dr...
Allegati: SI
Inserito da: Thomson Reuters
27/02/2015
 13.30
Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases
SOUTH SAN FRANCISCO, CA, February 27, 2015 - Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is joining forces on February 28 with patients and health care advocates in the United States and globally to raise awareness for Rare Disease Day(®).  Rare Disease Day is dedicated to elevating public understanding of rare diseases and calling attention to the special challenges faced by patients with rare diseases and the support community around them...
Allegati: NO
Inserito da: Thomson Reuters
27/02/2015
 13.30
Under Armour Signs Prolific Dutch Footballer Memphis Depay
Photo - http://photos.prnewswire.com/prnh/20150226/178269
Allegati: NO
Inserito da: PR Newswire
27/02/2015
 13.23
Novartis lung cancer drug Zykadia® recommended for EU approval in patients with ALK+ NSCLC previously treated with crizotinib
Novartis International AG / Novartis lung cancer drug Zykadia® recommended for EU approval in patients with ALK+ NSCLC previously treated with crizotinib . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. * If approved, Zykadia (ceritinib) would be the first treatment option for patients in Europe with ALK+ NSCLC previously treated with crizotinib * ALK+ NSCLC is driven by a...
Allegati: SI
Inserito da: Thomson Reuters
27/02/2015
 13.16
Toujeo® Receives Positive Opinion from the European Regulatory Authorities
Toujeo(®) Receives Positive Opinion from the European Regulatory Authorities Paris, France - February 27, 2015 - Sanofi announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Toujeo(®) (insulin glargine [rDNA origin] injection, 300 U/mL), a next-generation basal insulin for the treatment of adults with type 1 and type 2 diabetes...
Allegati: SI
Inserito da: Thomson Reuters
27/02/2015
 13.12
Personal Injury Practice Ltd Chooses Proclaim
Cheshire-based law firm, Personal Injury Practice (PIP), is implementing the Proclaim Case Management Software solution from Eclipse Legal Systems.
Allegati: NO
Inserito da: PR Newswire
27/02/2015
 13.06
Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix® paediatric study
* Study Meets Primary Endpoint and Achieves Low Bleeding Rates with Once- Weekly Prophylactic Dosing in Children * Results Support EU Regulatory Submission and Future Paediatric Indication Applications Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced positive top-line results of the Kids B-LONG Phase 3 clinical study that evaluated the safety, efficacy and pharmacokinetics of Alprolix® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] in children under age 12 with severe haemophilia B...
Allegati: SI
Inserito da: Thomson Reuters
27/02/2015
 13.00
CrossAmerica Partners LP: Reports Fourth Quarter and Full Year 2014 Results and Announces a 1.9% Increase in Its Quarterly Cash Distribution
CrossAmerica Partners LP Reports Fourth Quarter and Full Year 2014 Results and Announces a 1.9% Increase in Its Quarterly Cash Distribution ALLENTOWN, PA (February 27, 2015) - CrossAmerica Partners LP (NYSE: CAPL) (the "Partnership," "we," or "us") today reported its financial results for the quarter and year ended December 31, 2014 and announced that the Board of Directors of its general partner approved a 1...
Allegati: NO
Inserito da: Thomson Reuters
27/02/2015
 13.00
Finally, A Mobile Advertising Solution That Generates Revenues For Mobile Operators
One such channel is the otherwise unutilized ringback tone. By serving Audio Ads to calling parties, Mobile Operators tap into a global market that generates a potential 12 billion ad impressions daily. This is three times the number of internet searches.
Allegati: NO
Inserito da: PR Newswire
27/02/2015
 13.00
Central Europe Over-The-Counter Market (OTC) to Grow at High Annual Rate to 2019
The Central European OTC market report provides comparative analysis for six countries (Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic) and forecasts development for 2014-2019. Businesses that hold a stake in the market for over the counter drugs and dietary supplements in the Central European region will benefit from a new document prepared by the experienced professionals.
Allegati: NO
Inserito da: PR Newswire
27/02/2015
 13.00
Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors
BOSTON, Feb. 27, 2015 /PRNewswire/ -- PureTech, a science and technology R&D company focused on identifying, inventing and commercializing disruptive products and technologies in the healthcare sector, announced today the appointment of Christopher Viehbacher, former CEO and Member of the Board of Directors of Sanofi, to its Board of Directors.
Allegati: NO
Inserito da: PR Newswire
27/02/2015
 12.43
Boceprevir - Comprehensive Patent Search
Quickly grasp complexity
Allegati: NO
Inserito da: PR Newswire
27/02/2015
 12.30
Polyphthalamide Market $913,008.6 Million by 2019
Browse 114 Market Data Tables and 48 figures spread through 180 Pages and in-depth TOC on  "Polyphthalamide Market".
Allegati: NO
Inserito da: PR Newswire
27/02/2015
 12.29
Number of shares in Klövern as of 27 February 2015
After conversion of 316,026 Class A ordinary shares to Class B ordinary shares during the month of February the total number of shares in Klövern as of 27 February 2015 amounts to 932,437,980, of which 81,871,406 shares constitute Class A ordinary shares, 834,122,574 shares constitute Class B ordinary shares and 16,444,000 shares constitute preference shares...
Allegati: SI
Inserito da: Thomson Reuters
27/02/2015
 12.25
Global Cloud Security Software Market 2015-2019 with CA Technologies, McAfee, Symantec & TrendMicro
(http://www.researchandmarkets.com/research/q9h39b/global_cloud) has announced the addition of the "Global Cloud Security Software Market 2015-2019" report to their offering.
Allegati: NO
Inserito da: PR Newswire
12345678910...
Sezioni
Compleanni
Anniversari
Sandra Cecchini
1965, Bologna (Italia)
Jimmy Burns
1943, Dublin, Mississippi (Contea di Coahoma)
Joanne Woodward
1930, Thomasville (Usa)
Filippo Timi
1974, Perugia (Italia)
Alan Guth
1947, New Brunswick (Usa)
Segui i comunicati stampa su
Vai a informazione.it - Comunicati Stampa su Twitter Vai a informazione.it - Comunicati Stampa su Facebook Feed RSS per i comunicati stampa su informazione.it
Ultime Notizie